Background
Non-enhancing glioma typically have a favorable outcome, but approximately 19-44% have a highly aggressive course due to a glioblastoma genetic profile. The aim of this retrospective study is to use physiological MRI parameters of both perfusion and diffusion to distinguish the molecular profiles of glioma without enhancement at presentation.
Methods
Ninety-nine patients with non-enhancing glioma were included, in whom molecular status (including 1p/19q co-deletion status and IDH mutation) and pre-operative MRI (T2w/FLAIR, dynamic susceptibility weighted and diffusion weighted imaging) were available. Tumors were segmented semi-automatically using ITK-SNAP to derive whole tumor histograms of relative Cerebral Blood Volume (rCBV) and Apparent Diffusion Coefficient (ADC). Tumors were divided into three clinically relevant molecular profiles: IDH mutation (IDHmt) with (n=40) or without (n=41) 1p/19q co-deletion, and (n=18) IDH-wildtype (IDHwt). ANOVA, Kruskal-Wallis and Chi-Square analyses were performed using SPSS.
Results
rCBV (mean, median, 75 th and 85 th percentile) and ADC (mean, median, 15 th and 25 th percentile) showed significant differences across molecular profiles (p<0.01). Post-hoc analyses revealed that IDHwt and IDHmt 1p/19q co-deleted tumors showed significantly higher rCBV compared to IDHmt 1p/19q intact tumors: mean rCBV (mean, SD) 1.46 (0.59) and 1.35 (0.39) versus 1.08 (0.31), p<0.05. Also, IDHwt tumors showed significantly lower ADC compared to IDHmt 1p/19q co-deleted and IDHmt 1p/19q intact tumors: mean ADC (mean, SD) 1.13 (0.23) versus 1.27 (0.15) and 1.45 (0.20), p<0.001).
Conclusions
A combination of low ADC and high rCBV, reflecting high cellularity and high perfusion respectively, separates IDHwt from in particular IDHmt 1p/19q intact glioma.